Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial

Abstract : Background: Early hospital readmission of patients after discharge is a public health problem. One major cause of hospital readmission is dysfunctions in integrated pathways between community and hospital care that can cause adverse drug events. Furthermore, the French ENEIS 2 study showed that 1.3% of hospital stays originated from serious adverse drug events in 2009. Pharmacy-led medication reviews at hospital transitions are an effective means of decreasing medication discrepancies when conducted at admission or discharge. However, it is difficult to assess the true impact of pharmacist-led medication reviews in specific high-risk populations, such as pediatric and geriatric populations. In such a context, it is important to demonstrate the effectiveness of medication reconciliation as part of a standardized medication review process—in pediatric and elderly populations—on all-cause readmissions in a large randomized controlled clinical trial. The aim of this study is to assess the impact of the pharmacist-led medication review on the rate of readmissions and/or death after hospital discharge and patient treatment satisfaction.
Complete list of metadatas

Cited literature [23 references]  Display  Hide  Download

https://hal-amu.archives-ouvertes.fr/hal-01478931
Contributor : Marie-Anne Estève <>
Submitted on : Tuesday, February 28, 2017 - 2:52:42 PM
Last modification on : Wednesday, May 22, 2019 - 1:32:45 AM
Long-term archiving on : Monday, May 29, 2017 - 3:40:14 PM

File

Trials Renaudin et al 2017.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Pierre Renaudin, Karine Baumstarck, Aurélie Daumas, Marie-Anne Esteve, Stéphane Gayet, et al.. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials, BioMed Central, 2017, 11, pp.32 - 32. ⟨10.1186/s13063-017-1798-6⟩. ⟨hal-01478931⟩

Share

Metrics

Record views

232

Files downloads

212